A recent report [2] describes a neurodevelopmental clinical phenotype associated with a de novo RORB SNV in a patient affected by intellectual disability, attention deficit hyperactivity disorder (ADHD), and eyelid myoclonia with absences (Table 2). This evidence concerns the gene RORB and attention deficit-hyperactivity disorder.